This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (291)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Lionel Resnick, MD; Keith Veren; S. Zaki Salahuddin, MS; Sue Tondreau; Phillip D. Markham, PhD

JAMA. 1986;255(14):1887-1891.

Abstract
The stability of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) under environmental conditions encountered in a clinical or laboratory setting and its inactivation by commonly used chemical disinfectants were investigated. Under our experimental conditions utilizing a highly concentrated viral preparation, virus with an initial infectious titer of approximately 7 log₁₀ tissue culture infectious dose (TCID₅₀) per milliliter can be recovered for more than a week from an aqueous environment held at room temperature (23 to 27 °C) or at 36 to 37 °C. Virus recovery is reduced at a rate of approximately 1 log₁₀TCID₅₀ per 20 minutes when held at 54 to 56 °C. Dried and held at room temperature, HTLV-III/LAV retains infectivity for more than three days with a reduction of approximately 1 log₁₀TCID₅₀ per nine hours. Viral infectivity is undetectable and reduced more than 7 log₁₀TCID₅₀ within one minute with 0.5% sodium hypochlorite, 70% alcohol, or 0.5% nonidet-P40, and within ten minutes with 0.08% quaternary ammonium chloride or with a 1:1 mixture of acetone-alcohol. These results help provide a rational basis to prevent the accidental spread of HTLV-III/LAV in the laboratory or clinical setting.

(JAMA 1986;255:1887-1891)

Author Affiliations
From the Laboratory of Tumor Cell Biology, National Institutes of Health, Bethesda, Md (Dr Resnick and Mr Salahuddin); the Department of Cell Biology, Bionetics Research, Inc, Rockville, Md (Mr Veren, Ms Tondreau, and Dr Markham); and the Dermatology Department, Mount Sinai Hospital-Medical Center, Miami Beach, Fla (Dr Resnick).

Footnotes
Reprint requests to Bionetics Research, Inc, 1330 Piccard Dr, Rockville, MD 20850-4373 (Dr Markham).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Used condoms: a dangerous fetish?
Tremayne
Sex. Transm. Infect. 2009;85:483-483.
FULL TEXT  

Sharps injuries in UK health care: a review of injury rates, viral transmission and potential efficacy of safety devices
Elder and Paterson
Occup Med (Lond) 2006;56:566-574.
ABSTRACT | FULL TEXT  

Antimicrobial activity of UMFix tissue fixative
Cleary et al.
J. Clin. Pathol. 2005;58:22-25.
ABSTRACT | FULL TEXT  

Postexposure Prophylaxis in Children and Adolescents for Nonoccupational Exposure to Human Immunodeficiency Virus
Havens and Committee on Pediatric AIDS
Pediatrics 2003;111:1475-1489.
ABSTRACT | FULL TEXT  

The sclera, the prion, and the ophthalmologist
Mehta and Franks
Br J Ophthalmol 2002;86:587-592.
ABSTRACT | FULL TEXT  

Enhanced Binding of Antibodies to Neutralization Epitopes following Thermal and Chemical Inactivation of Human Immunodeficiency Virus Type 1
Grovit-Ferbas et al.
J. Virol. 2000;74:5802-5809.
ABSTRACT | FULL TEXT  

Decreased Splatter in Dermabrasion
Cox III et al.
Arch Facial Plast Surg 2000;2:23-26.
ABSTRACT | FULL TEXT  

Antiseptics and Disinfectants: Activity, Action, and Resistance
McDonnell and Russell
Clin. Microbiol. Rev. 1999;12:147-179.
ABSTRACT | FULL TEXT  

HIV Risk and Injecting Drug Use: Implications for Rural Jails
Kane and Dotson
Crime Delinquency 1997;43:169-185.
ABSTRACT  

Acquired Immunodeficiency Syndrome-- A Review and Update: History, Characteristics of Human Immunodeficiency Virus Infection, Its Replication, Biologic Factors, and Pathogenicity
Fox and McArthur
Arch Fam Med 1993;2:1068-1077.
ABSTRACT  

Patch Grafts of Dehydrated Cadaveric Dura Mater for Tube-Shunt Glaucoma Surgery
Brandt
Arch Ophthalmol 1993;111:1436-1439.
ABSTRACT  

Inactivation of Human Immunodeficiency Virus Type I in Human Milk: Effects of Intrinsic Factors in Human Milk and of Pasteurization
Orloff et al.
J Hum Lact 1993;9:13-17.
ABSTRACT  

HIV Transmission in a Dental Practice
Berman and Wenglin
ANN INTERN MED 1992;117:793-795.
ABSTRACT  

Adult Basic Life Support
JAMA 1992;268:2184-2198.
ABSTRACT  

Appendix Recommendations for prevention of HIV transmission in health-care settings
Home Health Care Management Practice 1991;3:68-75.
 

Iatrogenic Contamination of Multidose Vials in Simulated Use: A Reassessment of Current Patient Injection Technique
Plott et al.
Arch Dermatol 1990;126:1441-1444.
ABSTRACT  

Contamination Risks Associated With Electrosurgery
Sebben
Arch Dermatol 1990;126:805-808.
ABSTRACT  

IV Drug Use and AIDS: Public Policy and Dirty Needles
Stryker
Journal of Health Politics, Policy and Law 1989;14:719-740.
ABSTRACT  

Physical Properties of Aerosols Produced by Dermabrasion
Wentzell et al.
Arch Dermatol 1989;125:1637-1643.
ABSTRACT  

Infectious Potential of Aerosolized Particles
Sawchuk and Felten
Arch Dermatol 1989;125:1689-1692.
ABSTRACT  

Disinfection of Goldmann Tonometers Against Human Immunodeficiency Virus Type 1
Pepose et al.
Arch Ophthalmol 1989;107:983-985.
ABSTRACT  

Questions and Answers
JAMA 1988;260:2571-2572.
 

Can Acquired Immunodeficiency Syndrome and Creutzfeldt-Jakob Disease Be Transmitted via Otologic Homografts?
Glasscock et al.
Arch Otolaryngol Head Neck Surg 1988;114:1252-1255.
ABSTRACT  

Addendum
J Hum Lact 1987;3:149-150.
 

Leads From the MMWR
JAMA 1987;258:1441-1452.
 

Injection of Sodium Hypochlorite by Intravenous Drug Users
Froner et al.
JAMA 1987;258:325-325.
ABSTRACT  

Night of the Living Dead II: Slow Virus Encephalopathies and AIDS: Do Necromantic Zombiists Transmit HTLV-III/LAV During Voodooistic Rituals?
Greenfield
JAMA 1986;256:2199-2200.
ABSTRACT  

Leads from the MMWR
JAMA 1986;256:1857-1873.